Hallmarks of neurodegenerative diseases

被引:583
|
作者
Wilson III, David M. [1 ]
Cookson, Mark R. [2 ]
Van Den Bosch, Ludo [3 ,4 ]
Zetterberg, Henrik [5 ,6 ,7 ,8 ,9 ,10 ]
Holtzman, David M. [11 ]
Dewachter, Ilse [1 ]
机构
[1] Hasselt Univ, Biomed Res Inst, BIOMED, B-3500 Hasselt, Belgium
[2] Natl Inst Aging, Lab Neurogenet, NIH, Bethesda, MD 20892 USA
[3] Univ Leuven, Expt Neurol & Leuven Brain Inst LBI, Dept Neurosci, KU Leuven, B-3000 Leuven, Belgium
[4] Ctr Brain & Dis Res VIB, Lab Neurobiol, B-3000 Leuven, Belgium
[5] Sahlgrenska Acad Univ Gothenburg, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Molndal, Sweden
[6] Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden
[7] UCL Inst Neurol, Dept Neurodegenerat Dis, Queen Sq, London, England
[8] UK Dementia Res Inst UCL, London, England
[9] Hong Kong Ctr Neurodegenerat Dis, Clear Water Bay, Hong Kong, Peoples R China
[10] UW, Dept Med, Sch Med & Publ Hlth, Madison, WI USA
[11] Washington Univ St Louis, Hope Ctr Neurol Disorders, Knight Alzheimers Dis Res Ctr, Dept Neurol, St Louis, MO USA
基金
美国国家卫生研究院; 欧洲研究理事会; 瑞典研究理事会; 欧盟地平线“2020”;
关键词
AMYOTROPHIC-LATERAL-SCLEROSIS; UBIQUITIN-PROTEASOME SYSTEM; MOTOR-NEURON DISEASE; ALPHA-SYNUCLEIN TOXICITY; FRONTOTEMPORAL DEMENTIA; ALZHEIMERS-DISEASE; DNA-DAMAGE; PARKINSON-DISEASE; OXIDATIVE STRESS; AMYLOID-BETA;
D O I
10.1016/j.cell.2022.12.032
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Decades of research have identified genetic factors and biochemical pathways involved in neurodegenera-tive diseases (NDDs). We present evidence for the following eight hallmarks of NDD: pathological protein ag-gregation, synaptic and neuronal network dysfunction, aberrant proteostasis, cytoskeletal abnormalities, altered energy homeostasis, DNA and RNA defects, inflammation, and neuronal cell death. We describe the hallmarks, their biomarkers, and their interactions as a framework to study NDDs using a holistic approach. The framework can serve as a basis for defining pathogenic mechanisms, categorizing different NDDs based on their primary hallmarks, stratifying patients within a specific NDD, and designing multi-tar-geted, personalized therapies to effectively halt NDDs.
引用
收藏
页码:693 / 714
页数:22
相关论文
共 50 条
  • [21] Olfactory neurodegenerative pathology in neurodegenerative diseases
    Jellinger, K. A.
    Walker, L.
    Attems, J.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2014, 40 : 35 - 35
  • [22] Microglia in neurodegenerative diseases
    Yu Xu
    Ming-Zhu Jin
    Ze-Yong Yang
    Wei-Lin Jin
    Neural Regeneration Research, 2021, 16 (02) : 270 - 280
  • [23] Biomarkers in Neurodegenerative Diseases
    Ghosh, Arnab
    BIOMEDICINES, 2022, 10 (02)
  • [24] Microbiota and neurodegenerative diseases
    Marizzoni, Moira
    Provasi, Stefania
    Cattaneo, Annamaria
    Frisoni, Giovanni B.
    CURRENT OPINION IN NEUROLOGY, 2017, 30 (06) : 630 - 638
  • [25] Pain in neurodegenerative diseases
    Vujovic, S.
    Dragasevic, N.
    Petrovic, I.
    Stojkovic, T.
    Cancarevic, M.
    Stevic, Z.
    Stefanova, E.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 645 - 645
  • [26] Microglia in neurodegenerative diseases
    Xu, Yu
    Jin, Ming-Zhu
    Yang, Ze-Yong
    Jin, Wei-Lin
    NEURAL REGENERATION RESEARCH, 2021, 16 (02) : 270 - 280
  • [27] The lysosome and neurodegenerative diseases
    Zhang, Lisha
    Sheng, Rui
    Qin, Zhenghong
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2009, 41 (06) : 437 - 445
  • [28] Prions and neurodegenerative diseases
    Hope, J
    CURRENT OPINION IN GENETICS & DEVELOPMENT, 2000, 10 (05) : 568 - 574
  • [29] Mitoepigenetics and neurodegenerative diseases
    Stoccoro, A.
    Nicoli, V.
    Gallo, R.
    Mosca, L.
    Baldacci, F.
    Del Gamba, C.
    Cereda, C.
    Palmieri, I.
    Gagliardi, S.
    Smith, A. R.
    Lunnon, K.
    Coppede, F.
    Migliore, L.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 1738 - 1739
  • [30] Driving and neurodegenerative diseases
    Ergun Y. Uc
    Matthew Rizzo
    Current Neurology and Neuroscience Reports, 2008, 8